SGLT2 Inhibitors in Geographic Atrophy

Abroad (travel likely)RecruitingPHASE2

Conditions

Retinal Degeneration · Retinal Diseases · Eye Diseases · Geographic Atrophy · Pathological Conditions, Anatomical

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Washington University, St Louis, Missouri, United States
Contact: Study coordinator (Eve Adcock) · adcockl@wustl.edu · 314-286-2946
Contact: Principal Investigator (Rajendra S Apte, MD PhD)

Study leads

Rajendra S Apte, MD PhD
Principal Investigator
Washington University School of Medicine

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Study to Assess the Adverse Events and How Intravitreal ABBV-6628 Moves Through the Body of Adult Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Geographic Atrophy · Age-Related Macular Degeneration

Abroad (travel likely)RecruitingPHASE1, PHASE2

Carmel, United States · Reno, United States

A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

Geographic Atrophy · Macular Degeneration

Abroad (travel likely)RecruitingPHASE2

Tucson, United States · Fullerton, United States

Disulfiram for Treatment of Retinal Degeneration

Inherited Retinal Dystrophy Primarily Involving Sensory Retina

Abroad (travel likely)RecruitingPHASE1, PHASE2

Seattle, United States

Minocycline for Chronic Autoimmune Uveitis

Minocycline · Uveitis · Retinal Degeneration

Abroad (travel likely)RecruitingPHASE1, PHASE2

Guangzhou, China